| Literature DB >> 21941633 |
Luis V Rodríguez-Durán1, Blanca Valdivia-Urdiales, Juan C Contreras-Esquivel, Raúl Rodríguez-Herrera, Cristóbal N Aguilar.
Abstract
Tannin acyl hydrolase also referred as tannase is an enzyme with important applications in several science and technology fields. Due to its hydrolytic and synthetic properties, tannase could be used to reduce the negative effects of tannins in beverages, food, feed, and tannery effluents, for the production of gallic acid from tannin-rich materials, the elucidation of tannin structure, and the synthesis of gallic acid esters in nonaqueous media. However, industrial applications of tannase are still very limited due to its high production cost. Thus, there is a growing interest in the production, recovery, and purification of this enzyme. Recently, there have been published a number of papers on the improvement of upstream and downstream processing of the enzyme. These papers dealt with the search for new tannase producing microorganisms, the application of novel fermentation systems, optimization of culture conditions, the production of the enzyme by recombinant microorganism, and the design of efficient protocols for tannase recovery and purification. The present work reviews the state of the art of basic and biotechnological aspects of tannin acyl hydrolase, focusing on the recent advances in the upstream and downstream processing of the enzyme.Entities:
Year: 2011 PMID: 21941633 PMCID: PMC3175710 DOI: 10.4061/2011/823619
Source DB: PubMed Journal: Enzyme Res ISSN: 2090-0414
Figure 1Tannic acid hydrolysis pathway as proposed by Iibuchi et al. [60].
Figure 2Several hydrolytic reactions catalyzed by tannase.
Figure 3Selective hydrolysis of galloyl moieties of ellagitannins catalyzed by tannase.
Structural properties of some characterized tannases.
| Microorganism | Culture system | MW (kDa) | Subunits | Glycosylation (%) | Reference |
|---|---|---|---|---|---|
|
| SmF | 320 | 4 × 80 | 31.2 | [ |
|
| SmF | 230 | 6 × 37.8 | 8.0 | [ |
|
| SSF | 225 | 50 + 75 + 100 | n.d. | [ |
|
| SmF | 310 | 4 × (30 + 33) | 22.7 | [ |
|
| SmF | 250 | 2 × 120 | 64 | [ |
|
| SmF | 90 | 1 × 90 | 0 | [ |
|
| SmF | 50 | 1 × 50 | 0 | [ |
|
| Plant | 150 | 2 × 75 | n.d. | [ |
| leaves | 300 | 4 × 75 | |||
|
| SmF | 59 | 1 × 59 | 0 | [ |
n.d.: Not determined.
Physicochemical properties of some characterized tannases.
| Microorganism | Substrate | Temperature optimum (°C) | Stability temperature (°C) | pH optimum | Stability pH | pI |
|
| Reference |
|---|---|---|---|---|---|---|---|---|---|
|
| Methyl gallate | 40 | ≤50 | 6.0 | 5.0–7.0 | n.d. | 4.4 | n.d. | [ |
|
| Methyl gallate | 30 | ≤30 | 2.0, 8.0 | 2.0 | 4.4 | 1.9 | 830 | [ |
|
| Tannic acid | 50–60 | ≤60 | 5–5.5 | 5.0–5.5 | n.d. | 0.05 | n.d. | [ |
|
| Methyl gallate | 30 | ≤60 | 5.0–6.5 | 4.5–6.5 | n.d. | 0.6 | 5 | [ |
|
| Tannic acid | 60–70 | ≤90 | 6.0 | 3.5–7.0 | 3.8 | n.d. | n.d. | [ |
|
| Methyl gallate | 30–40 | ≤65 | 6.0 | 4.0–8.0 | n.d. | 103 | 4.25 | [ |
|
| Methyl gallate | 60 | ≤50 | 6.0 | 4.0–6.0 | 3.5 | 0.041 | 11.03 | [ |
|
| Tannic acid | 35 | ≤45 | 6.0 | 3.5–8.0 | 4.3 | n.d. | n.d. | [ |
|
| Methyl gallate | 60 | ≤60 | 6 | 4.5–7.5 | n.d. | 0.2 | 5 | [ |
|
| Tannic acid | 40 | ≤45 | 5.5 | 4.5–6.0 | n.d. | 7.35 | 83 | [ |
|
| Tannic acid | 50 | ≤70 | 6.0 | 3.5–7.5 | n.d. | n.d. | n.d. | [ |
|
| Methyl gallate | 40 | ≤45 | 8.0 | 7.5–9.0 | n.d. | 0.62 | n.d. | [ |
|
| Tannic acid | 55 | ≤55 | 5.5 | 4.5–6.5 | n.d. | 6.1 × 10−4 | 5.6 | [ |
|
| Tannic acid | 50 | ≤80 | 5.0 | 3.0–8.0 | n.d. | 32 | 1.11 | [ |
|
| Tannic acid | 25 | ≤30 | 5.5 | 4.5–6.0 | 5.8 | 1.05 | n.d. | [ |
|
| Tannic acid | 20 | ≤30 | 5.5 | 5.0–7.5 | 6.2 | 1.05 | n.d. | [ |
n.d.: Not determined.
Figure 4Phylogenetic tree showing the relationship between the reported sequences of the tannase-encoding gene.
Selected patents on tannase application published during the last 10 years.
| Year | Assignee | Title | Patent no. |
|---|---|---|---|
| 2001 | Quest International Nederland | Process for the production of beer having improved flavour stability. | EP 1122303 |
| 2002 | Unicafe Inc. | Tea extracts stabilized for long-term preservation and method of producing same. | USP 6,365,219 |
| 2002 | Purdue Research Foundation Pharmanex, Inc. | Tea catechin formulations and processes for making same. | USP 6,428,818 |
| 2004 | University of South Florida | Vasodilating compound and method of use. | USP 6,706,756 |
| 2004 | Purdue Research Foundation | Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer. | USP 6,759,064 |
| 2004 | Lipton, division of Conopco, Inc. | Cold brew tea. | USP 6,780,454 |
| 2004 | Kyowa Hakko Kogyo Co., Ltd. | Process for purification of proanthocyanidin oligomer. | USP 6,800,433 |
| 2004 | Lipton, division of Conopco, Inc. | Cold water infusing leaf tea. | USP 6,833,144 |
| 2006 | Nestec S A | Soluble coffee product. | EP 1726213 |
| 2006 | Eisai Co., Ltd. | Diagnostic agent and test method for colon cancer using tannase as index. | USP 7,090,997 |
| 2006 | Unilever Bestfoods | Black tea manufacture. | USP 7,108,877 |
| 2007 | Eisai R&D Man Co. Ltd. | Novel tannase gene and protein thereof. | EP 1837400 |
| 2008 | Probelte Pharma S A | Process for preparing pomegranate extracts. | EP 1967079 |
| 2008 | Novozymes, Inc. | Methods for degrading lignocellulosic materials. | USP 7,354,743 |
| 2008 | The Procter & Gamble Company | Foam-generating kit containing a foam-generating dispenser and a composition containing a high level of surfactant. | USP 7,402,554 |
| 2008 | Novozymes, Inc. | Methods for degrading or converting plant cell wall polysaccharides. | USP 7,413,882 |
| 2009 | Kirin Brewery | Method of enzymatically treating green tea leaves. | EP 2036440 |
| 2009 | Kao Corp. | Beverage packed in foam container. | EP 2036446 |
| 2009 | Kao Corp. | Green tea drink packed in container. | EP 2098121 |
| 2009 | Colgate-Palmolive Co. | Antiplaque oral composition containing enzymes and cyclodextrins. | USP 7,601,338 |
| 2009 | Novozymes, Inc. | Methods for enhancing the degradation or conversion of cellulosic material. | USP 7,608,689 |
| 2010 | Kao Corp. | Process for producing purified tea extract. | EP 2225952 |
| 2010 | University of California | Method for lowering blood pressure in prehypertensive individuals and/or individuals with metabolic syndrome. | USP 7,651,707 |
| 2010 | J.M. Huber Corporation | High-cleaning silica materials and dentifrice containing such ones. | USP 7,670,593 |
| 2010 | Novozymes, Inc. | Polypeptides having cellulolytic enhancing activity and nucleic acids encoding the same. | USP 7,741,466 |
| 2010 | Constellation Brands, Inc. | Grape extract, dietary supplement thereof, and processes therefore. | USP 7,767,235 |
| 2011 | Taiyo Kagaku Co., Ltd | Composition for inhibiting thrombosis. | USP 7,914,830 |
| 2011 | Danisco US Inc. | Polyol oxidases. | USP 7,919,295 |
Summary of protocols for tannase purification.
| Source | Production system | Extra-/intra-cellular | Operations | Purification factor | Recovery yield (%) | Reference |
|---|---|---|---|---|---|---|
|
| SmF | Extracellular | Aluminum oxide treatment, ultrafiltration (30 and 100 kDa), and gel filtration (Sephadex G-200). | 6.32 | 0.51 | [ |
|
| SmF | Intracellular | Ammonium sulfate and tannic acid precipitation, ionic exchange (DEAE-cellulose), gel filtration chromatography (Sephadex G-200), and acetone fractionation. | 31 | 49 | [ |
|
| SmF | Extracellular | Ammonium sulfate precipitation and ATPS extraction | 2.7 | 82.5 | [ |
|
| SmF | Extracellular | Ammonium sulfate precipitation and ionic exchange chromatography (DEAE-cellulose) | 39.7 | 19.3 | [ |
|
| SmF | Intracellular | Ultrafiltration (100 and 200 kDa) and high-pressure size-exclusion chromatography (SW 300). | 29.1 | 15.1 | [ |
|
| SmF | Intracellular | Concentration with PEG 6000, ionic exchange (DEAE-Sephadex), and gel filtration chromatography (Sephadex G-150). | 29 | 2.7 | [ |
|
| SmF | Intracellular | Gel filtration (Sephadex G-150) and ionic exchange chromatography (DEAE-Sephadex). | 51 | 20 | [ |
|
| SSF | Extracellular | Ultrafiltration (1 kDa), ionic exchange (DEAE-cellulose), and gel filtration chromatography (Sephacryl S-300). | 46 | 0.3 | [ |
|
| SmF | Extracellular | Ionic exchange (DEAE-Sephadex), gel filtration (Sephadex G100), ultracentrifugation. | 12.8 | 11.5 | [ |
|
| SmF | Extracellular | Pervaporation, rivanol precipitation, ionic exchange (ECTEOLA-cellulose), ultrafiltration, and gel filtration chromatography (Sepharose 6B and Sephadex G200). | 613 | 7.3 | [ |
|
| SmF | Intracellular | Ammonium sulfate precipitation, ionic exchange (DEAE-cellulose) and gel filtration chromatography (Sephadex G-100). | 162 | 7.1 | [ |
|
| SmF | Intracellular | Ammonium sulfate precipitation and three ionic exchange chromatographic steps (Q Sepharose, Hydroxyapatite, and Mono Q columns). | 11.2 | 4.8 | [ |
|
| SmF | Intracellular | Affinity chromatography (poorly activated nickel chelate supports). | 15 | 95 | [ |
|
| SmF | Extracellular | Activated charcoal treatment, ammonium sulfate precipitation, ionic exchange (DEAE-cellulose), and gel filtration chromatography (Sephadex G-200). | 30.5 | 17.6 | [ |
|
| SSF | Extracellular | Ammonium sulfate precipitation and ionic exchange chromatography (DEAE-Sepharose). | 19.3 | 3 | [ |
|
| SmF | Intracellular | Ammonium sulfate precipitation, ionic exchange (DEAE-cellulose), and gel filtration chromatography (Sephadex G-200). | 24 | 18.5 | [ |
|
| SmF | Extracellular | Ultrafiltration (100 kDa) and gel filtration chromatography (Sephadex G-200). | 135 | 91 | [ |
|
| SmF | Extracellular | Ammonium sulfate precipitation and ionic exchange chromatography (DEAE-cellulose). | 7.9 | 1.6 | [ |
|
| SmF | Extracellular | Ammonium sulfate precipitation and ionic exchange chromatography (DEAE-cellulose). | 10.5 | 0.9 | [ |